000			04371cam a2200565 i 4500
001			ocn865830589
003			OCoLC
005			20221128212428.0
006			m d
007			cr |||||||||||
008			130816s2013 nyua ob 001 0 eng
010			_a 2019713832
040			_aDLC _beng _erda _cDLC _dYDXCP _dCNSPO _dN$T _dEBLCP _dAU@ _dSTF _dE7B
019			_a923672973 _a928194735
020			_a9781629480411 _qebook
020			_a162948041X
020			_z9781628089905 _qhardcover
035			_a652533 _b(N$T)
035			_a(OCoLC)865830589 _z(OCoLC)923672973 _z(OCoLC)928194735
072		7	_aHEA _x039000 _2bisacsh
072		7	_aMED _x014000 _2bisacsh
072		7	_aMED _x022000 _2bisacsh
072		7	_aMED _x112000 _2bisacsh
072		7	_aMED _x045000 _2bisacsh
049			_aMAIN
245	0	0	_aSystemic lupus erythematosus (SLE) : _bprevalence, pathophysiology, and prognosis _c _h[E-Book]
264		1	_aNew York : _bNova Biomedical, _c[2013]
300			_a1 online resource.
336			_atext _btxt _2rdacontent
337			_acomputer _bc _2rdamedia
338			_aonline resource _bcr _2rdacarrier
490	1		_aImmunology and immune system disorders
504			_aIncludes bibliographical references and index.
588			_aDescription based on print version record.
505	0		_aSYSTEMIC LUPUS ERYTHEMATOSUS (SLE): PREVALENCE, PATHOPHYSIOLOGY AND PROGNOSIS; SYSTEMIC LUPUS ERYTHEMATOSUS (SLE): PREVALENCE, PATHOPHYSIOLOGY AND PROGNOSIS; Library of Congress Cataloging-in-Publication Data; Contents; Preface; Chapter 1: Illustrated Overview of the Prevalence and Clinical Symptoms of Systemic Lupus Erythematosus; Abstract; Introduction; Epidemiology; Constitutional Symptoms; Manifestations of the Involvement of Specific Organs; Gastrointestinal Disease: Digestive System; Renal Disease: Lupus Nephritis; Ophthalmologic Findings; Conclusion; References.
505	8		_aChapter 2: The Pathophysiology of Systemic Lupus ErythematosusAbstract; Introduction; Genetic Susceptibility; Environmental Triggers; The Source of Autoantigens in SLE; Sex Hormones and SLE; B- and T-Cell Hyperactivity; Autoantibodies in SLE; Cytokines in SLE; Conclusion; References; Chapter 3: MBL and MBL Genotypes in SLE; Abstract; Introduction; References; Chapter 4: Novel Biological Activitiesof Autoantibodies as the Potential Markers of Systemic Lupus Erythematosus; Abstract; Abbreviations; 1. Introduction; 2. Methods; 3. Results and Discussion; Conclusion; References.
505	8		_aChapter 5: Cytokines in Systemic Lupus Erythematosus (SLE): Clinical Aspects and PrognosticsAbstract; Introduction; Conclusion; References; Chapter 6: Prognosis in Systemic Lupus Erythematosus; Abstract; Systemic Lupus Erythematosus Development and Cardiovascular Involvement; SLE Improved Survival and Therapies; Regular Treatment for SLE; Conclusion; Grants; References; Chapter 7: Autoantibody-Producing RP105-Negative B Cells in Humans and a Murine Model of Lupus Erythematosus; Abstract; Introduction; Conclusion; References; EDITOR CONTACT INFORMATION; Index.
520			_aSystemic lupus erythematosus (SLE) is one of the prototypical systemic autoimmune diseases characterized by inflammation, immune complex deposition, and vasculitis. Patients with SLE show various symptoms and clinical images, both constitutional and specific organ symptoms. They include the skin, joints, muscles, kidneys, lungs, nervous system, and blood vessels. Although the etiology of the disease is still unclear, genetic, hormonal, immunologic abnormalities and environmental factors complicatedly play important roles in the pathophysiology in SLE. It is evident that multiple genes show gen.
590			_aMaster record variable field(s) change: 050, 082, 650
650		0	_aSystemic lupus erythematosus.
700	1		_aKoarada, Syuichi, _eeditor of compilation.
830		0	_aImmunology and immune system disorders.
856	4	0	_uhttps://search.ebscohost.com/login.aspx?custid=ns123844&authtype=ip,shib&direct=true&scope=site&db=nlebk&db=nlabk&AN=652533 _yKingston Hospital NHS Foundation Trust OpenAthens account holders click here for access
938			_aYBP Library Services _bYANK _n11241699
938			_aEBSCOhost _bEBSC _n652533
938			_aebrary _bEBRY _nebr10784531
938			_aProQuest Ebook Central _bEBLB _nEBL3023281
942			_n0
994			_a92 _bN$T
999			_c91468 _d91468